Research

Key Research Results
(Click highlighted text to view papers)

Richter S, Vandezande K, Chen N, Zhang K, Sutherland J, Anderson J, Han L, Panton R, Branco P, Gallie B. Sensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastoma. Am J Hum Genet. 2003 Feb;72(2):253-69.

Noorani HZ, Khan HN, Gallie BL, Detsky AS. Cost comparison of molecular versus conventional screening of relatives at risk for retinoblastoma. Am J Hum Genet. 1996 Aug; 59(2):301-7.


Brenda Gallie - Selected Research
Click here for complete PubMed listing

DiCiommo D, Gallie BL, Bremner R. Retinoblastoma: the disease, gene and protein provide critical leads to understand cancer. Semin Cancer Biol. 2000 Aug;10(4):255-69.


Beata Piovesan - Selected Research
Click here for complete PubMed listing

Piovesan B, Pennell N, Berinstein NL. Human lymphoblastoid cell lines expressing mutant p53 exhibit decreased sensitivity to cisplatin-induced cytotoxicity. Oncogene. (1998 Nov 5) 17(18):2339-50.


Nadia Prigoda - Selected Research
Click here for complete PubMed listing

Prigoda NL, Nassuth A, Mable BK. Phenotypic and genotypic expression of self-incompatibility haplotypes in Arabidopsis lyrata suggests unique origin of alleles in different dominance classes. Molecular Biology and Evolution 22, 7, 1609-20.


Diane Rushlow - Selected Research
Yager TD, Baron L, Batra R, Bouevitch A, Chan D, Chan K, Darasch S, Gilchrist R, Izmailov A, Lacroix JM, Marchelleta K, Renfrew J, Rushlow D, Steinbach E, Ton C, Waterhouse P, Zaleski H, Dunn JM, Stevens J. High performance DNA sequencing, and the detection of mutations and polymorphisms, on the Clipper sequencer. Electrophoresis. 1999 Jun; 20(6):1280-300.

Bremner R, Du DC, Connolly-Wilson MJ, Bridge P, Ahmad KF, Mostachfi H, Rushlow D, Dunn JM, Gallie BL. Deletion of RB exons 24 and 25 causes low-penetrance retinoblastoma. Am J Hum Genet. 1997 Sep; 61(3):556-70.


Kirk Vandezande - Selected Research
Cohen JH, Faughnan ME, Letarte M, Vandezande K, Kennedy SJ, Krahn MD.Cost comparison of genetic and clinical screening in families with hereditary hemorrhagic telangiectasia. Am J Med Genet A. 2005 (Aug): 153-60.

Evans AJ, Gallie BL, Jewett MA, Pond GR, Vandezande K, Underwood J, Fradet Y, Lim G, Marrano P, Zielenska M, Squire JA. Defining a 0.5-mb region of genomic gain on chromosome 6p22 in bladder cancer by quantitative-multiplex polymerase chain reaction. Am J Pathol. 2004 Jan;164(1):285-93.

George W. Blazenko and Kirk Vandezande. The product differentiation hypothesis for corporate trade credit. Management and Decision Economics 24,6-7 (Sep-Nov 2003), 457-69.

George W. Blazenko and Kirk Vandezande. Corporate holding of finished goods inventories. Journal of Economics and Business 55,3 (May-June 2003), 255-266.

Jonathan B. Berk, Eric Hughson and Kirk Vandezande. The Price is Right, But are the Bids? An Investigation of Rational Decision Theory. The American Economic Review 86,4 (Sep 1996), 954-970.


E (Katherine) Zhang - Selected Research
Zhang E, Nowak I, Rushlow D, Gallie BL, Lohmann DR. Patterns of missplicing caused by RB1 gene mutations in patients with retinoblastoma and association with phenotypic expression. Human Mutation 2008 Apr 29(4):475-84.

E Zhang and Thomas Ferenci. OmpF changes and the complexity of Escherichia coli adaptation to prolonged lactose limitation. FEMS Microbiology Letters 176,2 (15 July 1999), 395-401.